SAN DIEGO, Jan. 18, 2017 -- Square 1 Bank, a division of Pacific Western Bank, today announced that it has provided a $5 million credit facility to new client Argonaut Manufacturing Services, a leading contract manufacturer for biotech companies. Proceeds from the facility will support capital expenditures associated with the company’s recent expansion.
Headquartered in Carlsbad, CA, Argonaut provides contract manufacturing for top suppliers of molecular diagnostic and life science reagents and consumables. The company’s experienced team supports all product stages, from launch to revitalization, with services such as project planning, supplier management and global logistics. Clients benefit by receiving products compliant with applicable regulations and savings realized through cost variabilization.
“With business expanding and the opportunity to offer more services to our clients, Square 1 was our top choice for support,” stated Wayne Woodard, chief executive officer of Argonaut MS. “Square 1 definitely demonstrated their experience in helping life sciences entrepreneurs. They took the time to understand our business and long-term strategy, and then delivered exactly what we needed.”
“Argonaut’s leadership team has more than 100 years of operational experience, so they are well equipped to address most any supply chain challenge,” added Rilus Graham, senior vice president in Square 1’s life sciences practice. “With venture backing from Telegraph Hill Partners and the additional support of this credit facility, Argonaut is poised for growth. Square 1 is excited to support the company in its mission to accelerate innovation and unlock hidden potential in life science supply chains.”
About Square 1 Bank
Square 1 Bank is a division of Pacific Western Bank, a Los Angeles-based commercial bank with over $21 billion in assets. A full service financial services partner to entrepreneurs and their investors, Square 1 provides clients flexible resources and attentive service to help their companies grow. Square 1 offers a broad range of venture debt, treasury and cash management solutions through offices in top innovation centers: Atlanta, Austin, the Bay Area, Boston, Chicago, Denver, Durham, Los Angeles, Minneapolis, New York, San Diego, Seattle and Washington, DC. Pacific Western Bank is a wholly-owned subsidiary of PacWest Bancorp (NASDAQ:PACW). For more information, visit www.square1bank.com.
About Argonaut Manufacturing Services
Argonaut MS provides contract manufacturing in the life science and biotech arena for clients looking to leverage their supply chain. With experience supporting product launch, scale-up and revitalization, Argonaut MS houses over 7500 sq.ft. of clean room production area and 3000 sq. ft. of “research use only” manufacturing space at their headquarters in Carlsbad, CA. Argonaut MS is backed by the venture capital team, Telegraph Hill Partners. For more information, visit www.argonautms.com
Media Contact: Square 1 Bank, a division of Pacific Western Bank Dee McDougal 919.597.7479 [email protected]


Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Apple Turns 50: From Garage Startup to AI Crossroads
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
First Western Ship Transits Strait of Hormuz Since Iran War Began
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Britain Courts Anthropic Amid US Defense Department Dispute 



